drugset / Trial / NCT01746485

Three Times Daily Dosing of UT-15C

NCT01746485

Phase 1 Completed 19 enrolled United Therapeutics
NaSingle-groupOpen-label

Summary

To evaluate the pharmacokinetics of three-times daily dosing of UT-15C in healthy volunteers

Timeline

Start
2012-07
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Treprostinil Other / unclassified 0.5 mg Oral

Indications

No indication recorded.